Search Results

Editorial [Hot topic: The Role of Pemetrexed in Lung Cancer (Guest Editors: Daoyuan Wang and Jianxing He)]

Authors: Wang, Daoyuan; He, Jianxing

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 1-1(1)

Publisher: Bentham Science Publishers

The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer

Authors: Konopa, Krzysztof; Jassem, Jacek

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 2-11(10)

Publisher: Bentham Science Publishers

Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)

Authors: Giovannetti, Elisa; Honeywell, Richard; Hanauske, Axel R.; Tekle, Christina; Kuenen, Bart; Sigmond, Jennifer; Giaccone, Giuseppe; Peters, Godefridus J.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 12-28(17)

Publisher: Bentham Science Publishers

Role of Pemetrexed and Platinums Combination in Patients with Non- Small Cell Lung Cancer

Authors: Chen, Manyin; Shao, Wenlong; He, Jianxing; Wang, Daoyuan

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 29-36(8)

Publisher: Bentham Science Publishers

The Role of Pemetrexed in Advanced Non Small-Cell Lung Cancer: Special Focus on Pharmacology and Mechanism of Action

Authors: Joerger, M.; Omlin, A.; Cerny, T.; Fruh, M.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 37-47(11)

Publisher: Bentham Science Publishers

Predictive Markers for Haematological Toxicity of Pemetrexed

Authors: Kao, S. C.H.; Phan, V. H.; Clarke, S. J.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 48-57(10)

Publisher: Bentham Science Publishers

The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer

Author: Tucker, Steven

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 58-60(3)

Publisher: Bentham Science Publishers

The Role of Pemetrexed Combined with Gemcitabine for Non-Small-Cell Lung Cancer

Authors: Ngeow, Joanne; Toh, Chee-Keong

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 61-66(6)

Publisher: Bentham Science Publishers

The Role of Chemotherapy and Radiation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Authors: Wagner, Timothy D.; Yang, Gary Y.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 67-73(7)

Publisher: Bentham Science Publishers

The Role of Pemetrexed in Lung Adenocarcinoma, Mixed Subtype with Bronchioloalveolar Carcinoma Features

Authors: Duruisseaux, Michael; Cadranel, Jacques; Perol, Maurice; Arpin, Dominique

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 74-77(4)

Publisher: Bentham Science Publishers

Pemetrexed: Potential Role in the Adjuvant Chemotherapy of Non-Small Cell Lung Cancer

Author: Vincent, Mark

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 78-84(7)

Publisher: Bentham Science Publishers

Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer

Authors: Li, Tianhong; Lara Jr., Primo N.; Mack, Philip C.; Perez-Soler, Roman; Gandara, David R.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 85-94(10)

Publisher: Bentham Science Publishers

Talaporfin sodium

Authors: Wang, S; Bromley, Elizabeth; Xu, Leon; Chen, James C; Keltner, Llew

Source: Expert Opinion on Pharmacotherapy, Volume 11, Number 1, January 2010 , pp. 133-140(8)

Publisher: Informa Healthcare

Identification of ribosomal protein L19 as a novel tumor antigen recognized by autologous cytotoxic T lymphocytes in lung adenocarcinoma

Authors: Kuroda, Koji; Takenoyama, Mitsuhiro; Baba, Tetsuro; Shigematsu, Yoshiki; Shiota, Hironobu; Ichiki, Yoshinobu; Yasuda, Manabu; Uramoto, Hidetaka; Hanagiri, Takeshi; Yasumoto, Kosei

Source: Cancer Science, Volume 101, Number 1, January 2010 , pp. 46-53(8)

Publisher: Blackwell Publishing

Significance of thymidylate synthase for resistance to pemetrexed in lung cancer

Authors: Ozasa, Hiroaki; Oguri, Tetsuya; Uemura, Takehiro; Miyazaki, Mikinori; Maeno, Ken; Sato, Shigeki; Ueda, Ryuzo

Source: Cancer Science, Volume 101, Number 1, January 2010 , pp. 161-166(6)

Publisher: Blackwell Publishing

Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplification

Authors: Yoshida, Takeshi; Okamoto, Isamu; Okamoto, Wataru; Hatashita, Erina; Yamada, Yuki; Kuwata, Kiyoko; Nishio, Kazuto; Fukuoka, Masahiro; Jänne, Pasi A.; Nakagawa, Kazuhiko

Source: Cancer Science, Volume 101, Number 1, January 2010 , pp. 167-172(6)

Publisher: Blackwell Publishing

Knock down of the dual functional protein apurinic /apyrimidinic endonuclease 1 enhances the killing effect of hematoporphrphyrin derivative-mediated photodynamic therapy on non-small cell lung cancer cells in vitro and in a xenograft model

Authors: Yang, Zhen-Zhou; Li, Meng-Xia; Zhang, Yun-Song; Xiang, De-Bing; Dai, Nan; Zeng, Lin-Li; Li, Zeng-Peng; Wang, Ge; Wang, Dong

Source: Cancer Science, Volume 101, Number 1, January 2010 , pp. 180-187(8)

Publisher: Blackwell Publishing

Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer

Authors: Yamada, Kazuhiko; Nakao, Masao; Fukuyama, Chikara; Nokihara, Hiroshi; Yamamoto, Noboru; Sekine, Ikuo; Kunitoh, Hideo; Ohe, Yuichiro; Ohki, Emiko; Hashimoto, Junichi; Tamura, Tomohide

Source: Cancer Science, Volume 101, Number 1, January 2010 , pp. 188-195(8)

Publisher: Blackwell Publishing

Survival and mortality for colorectal cancer

Source: SourceOECD Social Issues/Migration/Health, Volume 2009, Number 16, December 2009 , pp. 115-116(2)

Publisher: OECD - Organisation for Economic Co-operation and Development

Updated treatment guidelines for stage IV NSCLC

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 593, 2009-12-12 , pp. 2-2(1)

Publisher: Adis International